Remifentanil Injection Shortage
Last Updated: November 27, 2023
Status: Current
Products Affected - Description
-
- Remifentanil lyophilized powder for injection, Fresenius Kabi, 5 mg, vial, 10 count, NDC 63323-0725-10
- Remifentanil lyophilized powder for injection, Hikma, 1 mg, vial, 10 count, NDC 00143-9391-10
Reason for the Shortage
-
- Fresenius Kabi did not provide a reason for the shortage.
- Hikma did not provide a reason for the shortage.
- Viatris did not provide a reason for the shortage.
Available Products
-
- Ultiva lyophilized powder for injection, Mylan Institutional (Viatris), 1 mg, vial, 10 count, NDC 72078-0034-01
- Ultiva lyophilized powder for injection, Mylan Institutional (Viatris), 2 mg, vial, 10 count, NDC 72078-0035-02
- Ultiva lyophilized powder for injection, Mylan Institutional (Viatris), 5 mg, vial, 10 count, NDC 67457-0198-10
- Remifentanil lyophilized powder for injection, Fresenius Kabi, 1 mg, vial, 10 count, NDC 63323-0723-03
- Remifentanil lyophilized powder for injection, Fresenius Kabi, 2 mg, vial, 10 count, NDC 63323-0724-05
- Remifentanil lyophilized powder for injection, Hikma, 2 mg, vial, 10 count, NDC 00143-9392-10
- Remifentanil lyophilized powder for injection, Hikma, 5 mg, vial, 10 count, NDC 00143-9393-10
Estimated Resupply Dates
-
- Fresenius Kabi has remifentanil 5 mg vials on back order and the company estimates a release date of late-November to early-December 2023.
- Hikma has remifentanil 1 mg vials on back order and the company cannot estimate a release date.
Updated
Updated November 27, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 22, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.